(Q38190015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

review article

1 reference

title

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

chronic lymphocytic leukemia

8 March 2020

main subject

lymphocyte

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Smita Y Patel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Mary Lucas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Anna Schuh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Malini Bhole

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Rashmi Jain

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Siraj Misbah

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Helen Chapel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

21 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

277-282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

The immunodeficiency of chronic lymphocytic leukaemia

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9995-5

Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9995-5

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9995-5

Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9995-5

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9995-5

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9995-5

Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9995-5

Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction

21 January 2018

1 reference

12 December 2020

Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia

1 reference

12 December 2020

Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia

1 reference

12 December 2020

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial

1 reference

12 December 2020

Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes

1 reference

12 December 2020

Predictors of infection in chronic lymphocytic leukaemia (CLL)

1 reference

12 December 2020

1 reference

12 December 2020

Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia

1 reference

12 December 2020

Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphatic leukaemia

1 reference

12 December 2020

Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma

1 reference

12 December 2020

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia

1 reference

12 December 2020

Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia

1 reference

12 December 2020

Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.

1 reference

12 December 2020

Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study

1 reference

12 December 2020

Making sense of serotype-specific pneumococcal antibody measurements

1 reference

12 December 2020

Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin

1 reference

12 December 2020

Infections and serum IgG levels in patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation

1 reference

12 December 2020

Pharmacoeconomic advantages of subcutaneous versus intravenous immunoglobulin treatment in a Canadian pediatric center

1 reference

12 December 2020

Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

1 reference

12 December 2020

Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia

1 reference

12 December 2020

10.1007/S10875-014-9995-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 March 2020

1015442285

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24557494%20AND%20SRC:MED&resulttype=core&format=json